title: The anti-tumor effect of Euchema serra agglutinin on colon cancer cells in vitro and in vivo.
abstract: Eucheuma serra agglutinin (ESA) is a lectin derived from a marine red alga E. serra and binds specifically to mannose-rich sugar chains. Previous reports have indicated that ESA associates with several cancer cells via sugar chains on cell surfaces and induces apoptotic cell death. In this study, we investigated the effect of ESA on Colon26 mouse colon adenocarcinoma cells both in vitro and in vivo. ESA induced cell death against Colon26 cells in vitro, and the expression of caspase-3 and the translocation of phosphatidylserine in ESA-treated Colon26 cells suggested that this cell death was induced through apoptosis. An intravenous injection of ESA significantly inhibited the growth of Colon26 tumors in BALB/c mice; moreover, DNA fragmentation was detected in tumor cells following ESA treatment. These results indicated that ESA is effective as an anti-cancer drug not only in vitro but also in vivo. The side-effects of ESA were not considered to be serious because the decrease in body weight of the mice injected with it was negligible. These observations suggest that ESA has the potential to be an effective anti-tumor drug.
authors.affiliation: Faculties of Agriculture, Ehime University, 3-5-7 Tarumi Station, Matsuyama, Ehime 790-8566, Japan.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Fukuda
authors.forename: Takuya
authors.initials: T
authors.lastname: Sugahara
authors.forename: Masashi
authors.initials: M
authors.lastname: Ueno
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Fukuta
authors.forename: Yukari
authors.initials: Y
authors.lastname: Ochi
authors.forename: Koichi
authors.initials: K
authors.lastname: Akiyama
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Miyazaki
authors.forename: Seizo
authors.initials: S
authors.lastname: Masuda
authors.forename: Akihiro
authors.initials: A
authors.lastname: Kawakubo
authors.forename: Keiichi
authors.initials: K
authors.lastname: Kato
mesh_terms: D000373:Agglutinins / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D053148:Caspase 3 / Q000378:metabolism; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004253:DNA Nucleotidylexotransferase / Q000378:metabolism; D003856:Deoxyuracil Nucleotides / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry; D020287:In Situ Nick-End Labeling; D037102:Lectins / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D000461:Rhodophyta / Q000737:chemistry
chemical_list: D000373:Agglutinins; D000970:Antineoplastic Agents; D003856:Deoxyuracil Nucleotides; D037102:Lectins; C027078:deoxyuridine triphosphate; D004253:DNA Nucleotidylexotransferase; C505409:Casp3 protein, mouse; D053148:Caspase 3